BriaCell Therapeutics Corp (BCTX)

[EpicSage]

$BCTX announces peer-reviewed validation of its Bria-OTS+™ immunotherapy in JCI Insight. Backed by NCI data, the study highlights Bria-OTS+ cancer-killing potential and its role in addressing urgent unmet needs in oncology: https://globenewswire.com/news-release/2025/08/26/3139167/0/en/BriaCell-s-Bria-OTS-Mechanism-of-Action-Validated-in-Highly-Rated-Peer-Reviewed-Cancer-Journal.html